Latest News about CDNA
Recent news which mentions CDNA
58 Biggest Movers From Yesterday
May 24, 2022
From Benzinga
30 Stocks Moving In Monday's Mid-Day Session
May 23, 2022
From Benzinga
92 Biggest Movers From Friday
May 09, 2022
From Benzinga
55 Stocks Moving In Friday's Mid-Day Session
May 06, 2022
From Benzinga
These Charts Explain Why I'm Holding This Healthcare Company
April 29, 2022
Tickers
CDNA
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 09, 2022
From Benzinga
60 Biggest Movers From Yesterday
January 11, 2022
From Benzinga
45 Stocks Moving In Monday's Mid-Day Session
January 10, 2022
From Benzinga
3 Unstoppable Growth Stocks You Can Buy for Less Than $100 Right Now
November 29, 2021
From Motley Fool
7 Stocks to Buy in November in Light of Their October Dip
November 15, 2021
From InvestorPlace
Why Cathie Wood Is Buying Beaten-Down CareDx
November 06, 2021
From Motley Fool
66 Biggest Movers From Friday
November 01, 2021
From Benzinga
Mid-Afternoon Market Update: Gold Down 1%; A10 Networks Shares Gain Following Q3 Results
October 29, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 29, 2021
From Benzinga
From Benzinga
Why Are CareDx Shares Slumping Despite Q3 Earnings Beat?
October 29, 2021
Tickers
CDNA
From Benzinga
Why CareDx Stock Is Falling Today Despite a Positive Earnings Call
October 29, 2021
Tickers
CDNA
From Motley Fool
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
COVID 19 Stocks -- Vaccines, Diagnostics, or Treatments?
August 31, 2021
From Motley Fool